Chemistry: analytical and immunological testing – Composition for standardization – calibration – simulation,... – Particle count or volume standard or control
Reexamination Certificate
1999-10-12
2001-12-18
Wallenhorst, Maureen M. (Department: 1743)
Chemistry: analytical and immunological testing
Composition for standardization, calibration, simulation,...
Particle count or volume standard or control
C436S008000, C436S070000, C073S061650, C600S370000
Reexamination Certificate
active
06331435
ABSTRACT:
FIELD OF THE INVENTION
This invention relates to the measurement of erythrocyte sedimentation rate (ESR), and more particularly to a blood control standard for the quality control of the measurement of ESR.
BACKGROUND OF THE INVENTION
The ESR test measures the sedimentation rate of aggregated erythrocytes in plasma. The rate of sedimentation is an indirect means of quantitating Rouleaux formation as well as red cell aggregation. Sedimentation occurs because the apparent surface/volume ratio of the red cells decreases and the denser Rouleaux overcome the buoyant forces of the plasma and sink. Erythrocyte sedimentation depends upon an interrelationship of a number of inherent biologic variables. Anything that increases the tendency to form Rouleaux or red cell aggregation will accelerate the sedimentation rate. In vivo, the plasma concentrations of proteins and globulins as well as the shape of the red blood cells are the most important factors contributing to the ESR.
In most normal persons, sedimentation takes place slowly, but in a variety of disease states the rate is rapid and in some cases proportional to the severity of the disease. The ESR test has been utilized as an indirect measure of these disease states. However, the test is very non-specific in that values for “normal” ESR may be influenced by local conditions as well as the age and sex of the patient. Nonetheless, the ESR test is an extremely common test which plays a significant role in contemporary medical practice.
Westergren developed the technique of performing an ESR determination as described in a paper published in 1924. See Alf Westergren, “Die senkungscreaktion”, Ergegn. Inn. Med. Kinderheilk., 26:577 (1924). In the Westergren method, a blood sample is obtained by venepuncture and is thoroughly mixed with a suitable anticoagulant. Because the proteins and globulins in blood are unstable in vitro, at room temperature the test must be set up within two hours, or at 4E C within 6 hours. The blood-anticoagulant is thoroughly mixed by gentle repeated inversion and a clean dry standard Westergren-Katz tube is filled and adjusted to the ‘0’ mark. The tube is then placed in a strictly vertical position under room temperature conditions (18-25E C), not exposed to direct sunlight and free from vibrations and drafts. After a time period, usually one hour, the distance (x) from the bottom of the surface meniscus to the top of the column of sedimenting red cells (where the full density is apparent), is read in mm and recorded as the ESR value. The result is expressed as follows: ‘ESR (Westergren 1 hr)=x mm’. Variations in the materials and methods are known, however, the basic technique is relatively unchanged since its introduction.
Due to the manner in which ESR is measured, in addition to the biologic variables certain identifiable environmental and technical factors may influence the ESR test in misleading ways. For example, the following factors may affect the measurement of ESR:
Environmental Factors:
1. Temperature. The room-temperature during the test could lead to a misleadingly high ESR (higher temperatures) or low ESR (lower temperatures). Further, a variation of temperature during the test will also lead to misleading results.
2. Vibration. Vibration or movement of the testing apparatus during the test will result in misleading results.
Procedural Factors:
1. Positioning of tube. The correct or incorrect positioning of the tube at a perpendicular angle will affect test results.
2. Delay prior to test. A delay in performing the test beyond 2 hours of drawing the blood sample will create ambiguous results.
3. Insertion of tube in reservoir (for modified Westergren procedures). Failure to fully insert the tube to the bottom of the reservoir in certain modified Westergren procedures will affect the test results.
4. Unfamiliarity or failing to follow manufacturer's directions will affect test results.
Testing Materials Factors
1. Tube. Variations of the composition and/or length of the measurement tube will affect test results. For example, the use of glass vs. plastic tubes in either a Wintrobe or Westergren procedure will lead to variations in the observed sedimentation rate.
2. Anticoagulant. The anticoagulant used will affect test results.
3. Plasma. Changes in the plasma composition is a significant factor determining the measured ESR.
There currently is no known commercial control by which the foregoing, and other, factors can be eliminated as sources affecting test results. Accordingly, a given ESR measurement can only be accepted as within a relatively large range of error. This decreases the significance of the ESR test.
SUMMARY OF THE INVENTION
The present invention is a reference control designed to monitor the accuracy and precision of analytical methods for determining the sedimentation rate of human erythrocytes in whole blood specimens. The ESR control comprises a three component colloidal/emulsion suspension: (1) a synthetic plasma base, (2) a polymer having a high molecular weight in the range of between 15,000-500,000, and (3) mammalian red blood cells. In the preferred embodiment, the polymer used is Dextran, a polysaccharide. Dextran is known for its use as a plasma expander used for cell separation, but is used for a different purpose in the ESR control of the present invention. Here, the addition of Dextran to the synthetic plasma base serves the function of behaving similar to an abnormal increase of large plasma proteins such as Fibrinogen and Alpha 2 macro-globulins in whole blood. It has been proposed that abnormal increases in plasma protein concentrations cause an increase in aggregate formation resulting in an increased ESR. The Dextran and synthetic plasma base is a stable suspension that maintains the morphology of the red cells for long periods of time to allow for a controlled sedimentation of the cells. An ESR measurement using the ESR control should fall within a fairly narrow, predictable range. Measurements outside this range would therefore indicate flaws in the testing method.
REFERENCES:
patent: 2102785 (1937-12-01), Brooks
patent: 2727838 (1955-12-01), Dalter
patent: 2848368 (1958-08-01), Witt
patent: 2929764 (1960-03-01), Hultin et al.
patent: 3660037 (1972-05-01), Sokol
patent: 3873467 (1975-03-01), Hunt
patent: 4064118 (1977-12-01), Wong
patent: 4102810 (1978-07-01), Armstrong
patent: 4264470 (1981-04-01), Chastain, Jr. et al.
patent: 4299726 (1981-11-01), Crews et al.
patent: 4324686 (1982-04-01), Mundschenk
patent: 4358394 (1982-11-01), Crew et al.
patent: 4436821 (1984-03-01), Ryan
patent: 4489162 (1984-12-01), Hawkins et al.
patent: 4572899 (1986-02-01), Walker et al.
patent: 4704364 (1987-11-01), Carver et al.
patent: 4777139 (1988-10-01), Wong et al.
patent: 5316729 (1994-05-01), Orth et al.
patent: 5328822 (1994-07-01), McKinney
patent: 5380664 (1995-01-01), Carver et al.
patent: 5482829 (1996-01-01), Kass et al.
patent: 5529933 (1996-06-01), Young et al.
patent: 5863799 (1999-01-01), Hengstenberg
patent: 5888822 (1999-03-01), Hengstenberg
patent: 5894760 (1999-04-01), Chen et al.
patent: 6017764 (2000-01-01), Chen et al.
patent: 6051433 (2000-04-01), Hengstenberg
patent: 6124089 (2000-09-01), Ryan
patent: 6159682 (2000-12-01), Ryan
patent: PCT/US96/15628 (1997-04-01), None
Thomas, et al., Calibration and Validation for Erythrocyte Sedimentation Tests, Arch. Pathol. Lab. Med., vol. 117, Jul. 1993, p. 719-723.
Excerpt from Sedimatic™ User Manual & Technical Reference by Analysis Instrument (Date Unknown).
Equinox-SED Rate product information (Date Unknown).
ESR CHEX and ESR 8 Product Information (Date Uknown).
Bull et al., The Zeta Sedimentation Ratio, Blood, 40(4):550 (Oct. 1972).
De Castro et al., Valoracion de un sistema alternativo totalmente automatizado para la deteminacion de law velocidad de sedimentacion globular, Sangre 34(1):4-9 (1989).
International Committee for Standarization in haematology (ICSH), Recommendation for Measurement of Erythrocyte Sedimentation Rate of Human Blood, Am. J. Clin. Pathol. 68:505-512 (1981).
International C
Dobrusin & Thennisch
Streak Laboratories, Inc.
Wallenhorst Maureen M.
LandOfFree
Erythrocyte sedimentation rate control does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Erythrocyte sedimentation rate control, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erythrocyte sedimentation rate control will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2557227